Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT03752112

Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women

Sponsor: World Health Organization

Interventions Benzathine penicillin 2.4 million units Cefixime

Updated 6 times since 2018 Last updated: Jan 29, 2020 Started: Nov 22, 2019 Primary completion: Mar 30, 2021 Completion: Sep 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Syphilis Female and is currently ongoing. World Health Organization leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2022 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Recruiting PHASE1_PHASE2
Mar 2020 — Jan 2021 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Dec 2018 — Mar 2020 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

World Health Organization

Data source: World Health Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fortaleza, Brazil